Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer-Reference-Cited by-同舟云学术

Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer

Published:2018-08-03 Issue:9 Volume:48 Page:822-826
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Wakuda Kazushige¹,Kobayashi Haruki¹,Omori Shota¹,Nakashima Kazuhisa¹,Ono Akira¹,Kenmotsu Hirotsugu¹,Naito Tateaki¹,Murakami Haruyasu¹,Endo Masahiro²,Nakajima Takashi³,Takahashi Toshiaki¹

Affiliation:

1. Division of Thoracic Oncology, Shizuoka Cancer Center, Nagaizumi-cho, Suntou-gun, Shizuoka, Japan

2. Division of Diagnostic Radiology, Shizuoka Cancer Center, Nagaizumi-cho, Suntou-gun, Shizuoka, Japan

3. Division of Pathology, Shizuoka Cancer Center, Nagaizumi-cho, Suntou-gun, Shizuoka, Japan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/9/822/25552453/hyy107.pdf

Reference15 articles.

1. Small-cell lung cancer;van Meerbeeck;Lancet,2011

2. Current status of second-line treatment and novel therapies for small cell lung cancer;Tiseo;J Thorac Oncol,2007

3. Small cell lung cancer;Rosti;Ann Oncol,2006

4. A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer;Owonikoko;J Thorac Oncol,2012

5. Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: a pooled analysis of topotecan second-line trials;Ardizzoni;Eur J Cancer,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amrubicin;Reactions Weekly;2018-12